ArticleCancer immunology, immunotherapy : CII2017

Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.

Xiaopeng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.